| Ytd | -6.90% | |
| 1y | 20.90% |
| Open | 1.64 | Prev Close | 1.65 | Low | 1.61 | High | 1.68 | Mkt Cap | 123.81M |
| Vol | 91.76K | Avg Vol | 289.25K | EPS | -1.48 | P/E | N/A | Forward P/E | -1.09 |
| Beta | 1.79 | Short Ratio | 14.59 | Inst. Own | 33.74% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 1.74 | 200-d Avg | 1.87 | 1yr Est | 18.13 |
CBUS News
Gainers Capricor Therapeutics (NASDAQ:CAPR) stock rose 94.8% to $8.2 during Friday's pre-market
Cibus, Inc. (CBUS) Q2 2026 Earnings Call Transcript
Cibus (CBUS) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate o
Cibus NASDAQ: CBUS reported second-quarter 2026 revenue of $1.0 million, compared with $0.9 million
On Thursday, Cibus (NASDAQ:CBUS) discussed second-quarter financial results during its earnings call
Gainers Akanda (NASDAQ:AKAN) stock rose 109.4% to $10.49 during Thursday's after-market session
Cibus (NASDAQ:CBUS) reported quarterly losses of $(0.29) per share which missed the analyst consensu
Commercialization execution advances in Rice and Sustainable Ingredients United States and European
SAN DIEGO, July 30, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a technology company that h
Gainers NextCure (NASDAQ:NXTC) stock increased by 201.4% to $6.57 during Tuesday's regular sess
Gainers OSR Health (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-mark
Under new EU rules, crops improved without adding foreign DNA will be treated like conventionally br
SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”),
Cibus, Inc. (CBUS) Q1 2026 Earnings Call Transcript
Cibus (CBUS) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate o
Cibus NASDAQ: CBUS reported first-quarter 2026 results and said it is advancing toward commercializa
Cibus (NASDAQ:CBUS) reported quarterly losses of $(0.33) per share which met the analyst consensus e
SAN DIEGO, May 14, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading ag
Cibus (CBUS) might move higher on growing optimism about its earnings prospects, which is reflected
Represents achievement of strategic milestone for Cibus' anticipated first commercial offering in th
SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural tec
SAN DIEGO, April 15, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”),
LOS ANGELES, April 08, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Cibus , Inc. , (“ Cibus
Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technol
SAN DIEGO, March 26, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”),
Shares of Navan Inc (NASDAQ: NAVN) spiked in pre-market trading on better-than-expected Q4 results.
Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technol
SAN DIEGO, March 25, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”),
Jefferies analyst Laurence Alexander maintains Cibus (NASDAQ:CBUS) with a Hold and raises the pri
Cibus, Inc. (CBUS) Q4 2025 Earnings Call Transcript
Cibus (CBUS) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate o
Cibus (NASDAQ:CBUS) reported quarterly losses of $(0.42) per share which beat the analyst consensus
Cibus to utilize proprietary Rapid Trait Development System™ to enable development of durable resist
Soybean-related stocks exploded on Wednesday following President Donald Trump's latest comments
CBUS stock surged 23.81% in pre-market trading following Trump's trade escalation with China, ca
